Table 1.
Characteristics of 88 patients with diabetes type 2. Values are number (%) of patients or means±SD
| Characteristic | Value |
|---|---|
| Male | 56 (64) |
| Age (years) | 53 ± 10 |
| Diabetes-related risk factors | |
| Duration (years) | 9.8 ± 8.2 |
| Age at time of diagnosis of diabetes (years) | 44 ± 12 |
| HbA1C (%) | 7.4 ± 1.6 |
| Treatment | |
| Oral | 54 (61) |
| Insulin | 21 (24) |
| Oral and insulin | 11 (13) |
| Peripheral vascular disease | 9 (10) |
| Peripheral neuropathy | 19 (22) |
| Peripheral vascular and neuropathy | 11(13) |
| Body mass index (kg/m2) | 29.2 ± 5.7 |
| Waist circumference (cm) | 103 ± 15.0 |
| Hypertension | 47 (53) |
| Hypercholesterolaemia | 46 (52) |
| Family history of CAD | 52 (59) |
| Current smoking | 12 (14) |
| Medication | |
| Aspirin | 18 (21) |
| ACE inhibitors | 31 (35) |
| ARB | 18 (21) |
| Statins | 45 (51) |
| Total cholesterol (mmol/l) | 4.9 ± 1.1 |
| Low-density lipoprotein (mmol/l) | 3.2 ± .1.1 |
| High-density lipoprotein (mmol/l) | 1.4 ± 0.6 |
| Cholesterol/HDL ratio | 3.8 ± 1.3 |
| Triglycerides (mmol/l) | 2.0 ± 1.2 |
| Creatinine (mmol/l) | 78.5 ± 20.0 |
| Urine albumin/creatinine ratio | 12.4 ± 32.8 |
| Chain reactive protein (mg/l) | 8.3 ± 5.8 |
| Apolipoprotein A1 (g/l) | 1.4 ± 0.30 |
| Apolipoprotein B (g/l) | 0.9 ± 0.30 |
| Fibrinogen (g/l) | 3.9 ± 0.90 |